Ram Kumar Selvaraju
Researcher
Medicinal Chemistry, Organic Pharmaceutical Chemistry
Uppsala Biomedical Centre
Sweden
Biography
I am a biotechnologist and my interest incline toward molecular imaging,specializing in use of positron emission tomography (PET) as a tool in preclinical evaluation of novel tracers for diabetes and pancreatic cancer. Education: 2017, Researcher, Uppsala University (UU), Sweden. 2016-2017, Post doctoral researcher, UU, Sweden. 2011-2015, Ph. D. in Pharmacy, UU, Sweden. 2009-2011, M. Sc. in Medical Nuclide Techniques, UU, Sweden. 2005-2009, B.Tech in Biotechnology, VIT University, India.
Research Interest
Pre clinical evaluation of novel tracers for diabetes and pancreatic cancer.
Publications
-
Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, Eriksson B, Sörensen J, Korsgren O. Detection of metastatic insulinoma by positron emission tomography with [68Ga] exendin-4—a case report. The Journal of Clinical Endocrinology & Metabolism. 2014 May 1;99(5):1519-24.
-
Eriksson O, Selvaraju RK, Johansson L, Eriksson JW, Sundin A, Antoni G, Sörensen J, Eriksson B, Korsgren O. Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas. Journal of Nuclear Medicine. 2014 Mar 1;55(3):460-5.
-
Eriksson O, Espes D, Selvaraju RK, Jansson E, Antoni G, Sörensen J, Lubberink M, Biglarnia AR, Eriksson JW, Sundin A, Ahlström H. Positron emission tomography ligand [11C] 5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas. Diabetes. 2014 Oct 1;63(10):3428-37.
